Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights
August 16, 2021 16:05 ET
|
Sema4
85% test-volume growth (excluding COVID-19 tests) compared to same period in 2020 Recorded 56% growth in total revenue of $46.9 million Expanded health system partnerships to include NorthShore...
Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
August 11, 2021 08:00 ET
|
Sema4
SIOUX FALLS, S.D and STAMFORD, Conn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Avera Health, an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4, a...
Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
August 02, 2021 09:00 ET
|
Sema4
STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today...
Sema4 to Participate at Two Upcoming Investor Conferences in August
July 28, 2021 16:05 ET
|
Sema4
STAMFORD, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today...
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
July 22, 2021 09:15 ET
|
Sema4
Sema4 Holdings Corp (“Sema4”) to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional,...